Mei C, Xu G, Zheng C, Xie Y, et al. Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial. Haematologica 2025 Jun 12. doi: 10.3324/haematol.2024.287055.
PMID: 40501398